Duaklir Pressair (Aclidinium Brom/Formoterol Fum) Patent Expiration, LOE Window & CMS Spending

Duaklir Pressair (Aclidinium Brom/Formoterol Fum) by Azurity: FDA Orange Book LOE 2029-03-13, 0 AB generics, $85K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAzurity
FDA Application & PathwayN210595 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-03-13
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$85K
2024 Medicare Part D Spend$60K
2024 Medicaid Spend$26K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel